Pharma Equity Group A/S (CPH:PEG)

Denmark flag Denmark · Delayed Price · Currency is DKK
0.1420
+0.0025 (1.79%)
Mar 31, 2025, 1:32 PM CET
-60.56%
Market Cap 171.24M
Revenue (ttm) n/a
Net Income (ttm) -24.42M
Shares Out 1.23B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 773,033
Average Volume 457,350
Open 0.1430
Previous Close 0.1395
Day's Range 0.1420 - 0.1445
52-Week Range 0.1320 - 0.3800
Beta 1.07
RSI 43.64
Earnings Date Mar 20, 2025

About Pharma Equity Group

Pharma Equity Group A/S, through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement. Its products under development that are in Phase II clinical trials include RNX-011 for the treatment of bacterial peritonitis; RNX-021, RNX-022, and RNX-023 for the treatment of chronic skin ulcers; RNX-041 for the treatment of inflammatory bowel diseases, such as chrons and pouchitis; and RNX... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 1
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol PEG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.